Why GAMP® Matters
GAMP is crucial for several reasons. Firstly, to ensure product quality and safety. Computerized systems play a critical role in the development, production, distribution and oversight of pharmaceuticals, and GAMP helps ensure that these systems operate correctly, consistently, and reliably. This is vital for maintaining the quality and safety of pharmaceutical products.
Regulatory compliance is another significant aspect. Regulatory bodies such as the US Food and Drug Administration (US FDA) in the USA, European Medicines Agency (EMA) in Europe, and Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom (UK) play critical roles in ensuring that medications are safe, effective, and of high quality before they reach the patient.
Regulations are designed to ensure patient safety and product quality, making compliance the minimum standard to achieve. Regulatory bodies conduct meticulous inspections to verify adherence to GMP regulations. By complying with these standards, companies can maintain high-quality products and safeguard patient health.
GAMP provides a structured and pragmatic framework that helps organizations achieve and maintain regulatory compliance, ultimately ensuring the safety and quality of pharmaceutical products.
Quality Risk Management Approach
Quality risk management (QRM) is a systematic process for the assessment, control, communication, and review of risks through the pharmaceutical product lifecycle. In the context of GAMP, it is an iterative process used throughout the computerized system life cycle from concept to retirement, to manage risks associated with those systems. The GAMP 5 Guide (Second Edition) outlines an efficient yet comprehensive approach to computerized system QRM, which is essential for ensuring fitness for intended use.
Key Steps in the Quality Risk Management Process
1. Perform Initial Risk Assessment and Determine System Impact
- An initial risk assessment should be performed based on an understanding of business processes, user requirements, regulatory requirements, and known functional areas. This assessment helps determine whether the system is GxP-regulated and includes an overall assessment of system impact.
2. Identify Functions with Impact on Patient Safety, Product Quality, and Data Integrity
- Functions that have an impact on patient safety, product quality, and data integrity should be identified by building on information gathered during the initial risk assessment. This involves referring to relevant specifications and considering project approach, system architecture, and categorization of system components.
3. Perform Functional Risk Assessments and Identify Controls
- Functions identified should be assessed by considering possible hazards and how the potential harm arising from these hazards may be controlled. This may involve a detailed assessment that analyzes the severity of harm, likelihood of occurrence, and probability of detection. Appropriate controls should be identified based on the assessment, including modification of process design, system design, application of external procedures, and increasing the extent or rigor of verification activities.
4. Implement and Verify Appropriate Controls
- The control measures identified should be implemented and verified to ensure they have been successfully implemented. Controls should be traceable to the relevant identified risks, and the verification activity should demonstrate that the controls are effective in performing the required risk reduction.
5. Review Risks and Monitor Controls
- During periodic review of systems, or at other defined points, an organization should review the risks to verify that controls are still effective. This includes considering whether previously unrecognized hazards are present, previously identified hazards are no longer applicable, or the estimated risk associated with a hazard is no longer acceptable. The results of the evaluation should be fed back into the risk-management process, and corrective actions should be taken under change management if deficiencies are found.
Simply reading the GAMP® 5 Guide isn't enough to effectively validate systems. ISPE GAMP training courses equip professionals with the practical skills needed to apply these concepts to one’s projects and daily work. The training covers regulatory expectations and key GAMP concepts, as well as specific quality aspects for computer systems, infrastructure, mobile devices, applications, spreadsheets, and more.
To help professionals in pharmaceutical or biotech companies as well as suppliers of IT products and services stay up to date with the latest GAMP guidance and best practices, ISPE offers a variety of training events. Here are some upcoming ISPE GAMP training events:
The GAMP Basic Principles Three-Day Online Live Training Course will be held 7 – 9 April, 2025. The GAMP Basic Principles Two-Day In-Person Training Course will be held after the EU Annual meeting in London on 15 – 16 May, 2025. Additionally, the ISPE GAMP® Community of Practice UK Forum on 8 April, 2025, in Manchester, UK, provides a platform for professionals to discuss GAMP-related topics, share experiences, and network with peers.
Our training sessions are led by certified ISPE Instructors who are seasoned industry experts and frequent contributors to ISPE GAMP® guides, ensuring top-tier, real-world insights and expertise.
Learn more and register for an ISPE training course today. > Learn more and register for an ISPE training course today. <>
The GAMP® track at the 2025 ISPE Europe Annual Conference in London, UK, taking place 12 – 14 May, will feature several insightful sessions, including:
These sessions will provide valuable insights into the latest advancements and practical applications of GAMP® 5 Guide (Second Edition).
Learn More about GAMP® 5
For those looking to dive deeper into GAMP principles, the ISPE GAMP® 5 Guide is an invaluable resource—providing a risk-based approach to designing, developing, and maintaining computerized systems in a GxP-regulated environment and offering practical guidance on achieving and maintaining compliance.
Learn more about the GAMP® 5 Guide.
Conclusion
GAMP guidance is essential for ensuring the quality, safety, and compliance of pharmaceutical products. By adhering to GAMP guidance and participating in ISPE training events, professionals can stay informed and equipped to navigate the complexities of automated manufacturing in the pharmaceutical industry.
Join ISPE Today
Becoming a member of ISPE offers numerous benefits, including access to a vast network of professionals, exclusive training events, and valuable resources. As a member, you'll join more than 22,000 of your professional peers from over 120 countries in advancing solutions that lead to improved patient health. Membership provides access to 20+ complimentary ISPE Good Practice Guides, a robust library of on-demand training and e-learning resources, and much more. Learn more and consider joining today.
Become an ISPE member
